Recursion Pharmaceuticals (RXRX) Cash from Operations Growth (1y) (2021 - 2026)
Recursion Pharmaceuticals (RXRX) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 60.84% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 85.14% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.72% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 74.39% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | 38.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.54% |
| Dec 31, 2025 | 60.09% |
| Sep 30, 2025 | -98.16% |
| Jun 30, 2025 | 7.06% |
| Mar 31, 2025 | -28.99% |
| Dec 31, 2024 | -55.82% |
| Sep 30, 2024 | 18.78% |
| Jun 30, 2024 | -21.87% |
| Mar 31, 2024 | -39.53% |
| Dec 31, 2023 | -65.54% |
| Sep 30, 2023 | -33.70% |
| Jun 30, 2023 | -9.48% |
| Mar 31, 2023 | -194.74% |
| Dec 31, 2022 | 26.83% |
| Sep 30, 2022 | -65.04% |
| Jun 30, 2022 | -83.11% |
| Mar 31, 2022 | 351.63% |
| Dec 31, 2021 | -813.38% |
| Sep 30, 2021 | -69.86% |
| Jun 30, 2021 | -101.53% |